Return On Equity of ENDRA Life Sciences Inc. from 30 Sep 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ENDRA Life Sciences Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2017 to 30 Sep 2025.
  • ENDRA Life Sciences Inc. Return On Equity for the quarter ending 30 Sep 2025 was -538%, a 280% decline year-over-year.
  • ENDRA Life Sciences Inc. annual Return On Equity for 2024 was -211%, a 17% decline from 2023.
  • ENDRA Life Sciences Inc. annual Return On Equity for 2023 was -181%, a 36% decline from 2022.
  • ENDRA Life Sciences Inc. annual Return On Equity for 2022 was -132%, a 67% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

ENDRA Life Sciences Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -538% -396% -280% 01 Jul 2025 30 Sep 2025
Q2 2025 -283% -120% -74% 01 Apr 2025 30 Jun 2025
Q1 2025 -196% -12% -6.5% 01 Jan 2025 31 Mar 2025
Q4 2024 -211% -30% -17% 01 Oct 2024 31 Dec 2024
Q3 2024 -141% +58% +29% 01 Jul 2024 30 Sep 2024
Q2 2024 -162% +7.2% +4.2% 01 Apr 2024 30 Jun 2024
Q1 2024 -184% -34% -22% 01 Jan 2024 31 Mar 2024
Q4 2023 -181% -48% -36% 01 Oct 2023 31 Dec 2023
Q3 2023 -200% -80% -67% 01 Jul 2023 30 Sep 2023
Q2 2023 -170% -64% -61% 01 Apr 2023 30 Jun 2023
Q1 2023 -151% -52% -53% 01 Jan 2023 31 Mar 2023
Q4 2022 -132% -53% -67% 01 Oct 2022 31 Dec 2022
Q3 2022 -120% -42% -53% 01 Jul 2022 30 Sep 2022
Q2 2022 -105% -4.1% -4.1% 01 Apr 2022 30 Jun 2022
Q1 2022 -98% +47% +32% 01 Jan 2022 31 Mar 2022
Q4 2021 -79% +256% +76% 01 Oct 2021 31 Dec 2021
Q3 2021 -78% +415% +84% 01 Jul 2021 30 Sep 2021
Q2 2021 -101% +496% +83% 01 Apr 2021 30 Jun 2021
Q1 2021 -146% +383% +72% 01 Jan 2021 31 Mar 2021
Q4 2020 -335% +117% +26% 01 Oct 2020 31 Dec 2020
Q3 2020 -493% -166% -51% 01 Jul 2020 30 Sep 2020
Q2 2020 -598% -240% -67% 01 Apr 2020 30 Jun 2020
Q1 2020 -528% -191% -57% 01 Jan 2020 31 Mar 2020
Q4 2019 -451% -80% -22% 01 Oct 2019 31 Dec 2019
Q3 2019 -327% +78% +19% 01 Jul 2019 30 Sep 2019
Q2 2019 -358% -175% -95% 01 Apr 2019 30 Jun 2019
Q1 2019 -337% -208% -160% 01 Jan 2019 31 Mar 2019
Q4 2018 -371% -257% -225% 01 Oct 2018 31 Dec 2018
Q3 2018 -406% -287% -241% 01 Jul 2018 30 Sep 2018
Q2 2018 -183% 01 Apr 2018 30 Jun 2018
Q1 2018 -129% 01 Jan 2018 31 Mar 2018
Q4 2017 -114% 01 Oct 2017 31 Dec 2017
Q3 2017 -119% 01 Jul 2017 30 Sep 2017

ENDRA Life Sciences Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -211% -30% -17% 01 Jan 2024 31 Dec 2024
2023 -181% -48% -36% 01 Jan 2023 31 Dec 2023
2022 -132% -53% -67% 01 Jan 2022 31 Dec 2022
2021 -79% +256% +76% 01 Jan 2021 31 Dec 2021
2020 -335% +117% +26% 01 Jan 2020 31 Dec 2020
2019 -451% -80% -22% 01 Jan 2019 31 Dec 2019
2018 -371% -257% -225% 01 Jan 2018 31 Dec 2018
2017 -114% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.